A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2006
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006	CA2609296A1 Nanoparticulate and controlled release compositions comprising a cephalosporin
11/16/2006	CA2607954A1 Conjugate for targeting of drug
11/16/2006	CA2607486A1 Production of glucosamine from plant species
11/16/2006	CA2607267A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721904A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721617A2 Dental therapeutics containing parathyroid hormone
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1720878A1 Heteroaryl-fused pyrazolo derivatives
11/15/2006	EP1720825A1 New compounds, methods for their preparation and use thereof
11/15/2006	EP1720561A1 Botanical extract composition
11/15/2006	EP1720558A1 Composition and method for use in cartilage affecting conditions
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1416927B1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1244679B1 Purine derivatives
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863768A 8-aza-11-deoxy prostaglandin analogues
11/15/2006	CN1861801A Collagen wet-retaining face mask and preparation process thereof
11/15/2006	CN1861640A Preparation process of chito oligosaccharace hydrochloride
11/15/2006	CN1861591A Hesperetin derivant and preparation process thereof
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006	CN1861187A Medicated wine for treating rheumatosis and osteoarthropathy
11/15/2006	CN1861179A Pure traditional Chinese medicine composition and its prepn. method
11/15/2006	CN1861155A Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby
11/15/2006	CN1861141A Traditional Chinese medicine composition for treating cervical spondylosis, and its prepn. method
11/15/2006	CN1861136A Paederia foetida tea agent and its prepn. method
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861074A Application of derivative of hesperetin as anti-inflammatory and immune medicine
11/15/2006	CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284591C Safflower oil
11/15/2006	CN1284580C Bone Activating stasis transforming capsule
11/15/2006	CN1284579C Oral medicine for treating ischemic necrosis of femoral head and its preparation
11/15/2006	CN1284576C External-use Chinese medicine for treating osteoproliferation and its preparing method
11/15/2006	CN1284567C Medicinal liquid for treating osteoporosis and its preparation method
11/15/2006	CN1284541C Magnesium, potassium and calcium mixture and its usage
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135489 Cyclooxygenase inhibitors; antiinflammatory agents
11/14/2006	US7135477 Administering N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine as an antiinflammatory agent treating rheumatoid arthritis
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	CA2362233C Process for cross-linking hyaluronic acid to polymers
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2263846C Novel pyranoside derivatives
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118173A1 Trenadermal absorption preparation
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006117684A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
11/09/2006	WO2006117600A2 Double-stranded synthetic oligonucleotides useful for inducing apoptosis of osteoclasts for the treatment of osteopenic pathologies
11/09/2006	WO2006117217A2 Novel use of spiegelmers
11/09/2006	WO2006117184A2 Veterinary composition
11/09/2006	WO2006000577A3 Lxr agonists to promote bone homeostasis
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251653 Methods for treating interleukin-6 related diseases
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006	CA2607185A1 Intracellular active agents
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2602464A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719771A1 Pyrazoloquinolone derivative and use thereof
11/08/2006	EP1719757A1 Bicyclo derivative
11/08/2006	EP1719508A1 Use of histone deacetylase inhibitors for the prevention or treatment of joint destruction
11/08/2006	EP1719507A1 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718630A1 DIBENZO CHROMENE DERIVATIVES AND THEIR USE AS ER&bgr; SELECTIVE LIGANDS
11/08/2006	EP1718628A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718293A1 Oxydecahydronaphthalene modulators of hm74
11/08/2006	EP1718287A1 Method for treatment or prevention of osteoporosis in individuals with high bone turnover
11/08/2006	EP1718152A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/08/2006	EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1860236A Process for producing 1,4-dihydoxy-2-naphthoic acid
11/08/2006	CN1859918A Methods for treating acute and overuse sprain and strain using hyaluronic acid
11/08/2006	CN1859911A A pharmaceutical composition comprising a P2X7 receptor antagonist and a nonsteroidal anti inflammatory drug
11/08/2006	CN1859903A Use of EP2 selective receptor agonists in medical treatment
11/08/2006	CN1857738A Recombinant adenovirus vector for the gene therapy of rheumatoid arthritis
11/08/2006	CN1857713A Osteoporosis treating medicine
11/08/2006	CN1857712A Preparing process of calcium-adding hydrolyzed collagen preparation and its product and application

1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 820